Chemotherapy for ovarian cancer.
D000477:Alkylating Agents / Q000494:pharmacology / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000145:classification; D003520:Cyclophosphamide / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008938:Mitosis / Q000187:drug effects; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide